Dr. Joseph Michael Tremaglio, MD

Dr. Tremaglio practices at Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare.

Dr. Tremaglio's NPI, 1841519451, was assigned on May 21, 2010. Dr. Tremaglio graduated from University of Connecticut School of Medicine in 2010. Dr. Tremaglio holds Massachusetts license 254185.

Dr. Tremaglio's primary practice is Hartford Hospital, at 80 Seymour Street, Hartford, CT 06102 in Hartford County. The practice phone is (860) 545-5000.

Dr. Tremaglio's primary practice is Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare. Dr. Tremaglio is also affiliated with Manchester Memorial Hospital. The medical group on file is Starling Physicians. Dmand AI also links Dr. Tremaglio to 1 more hospital, 3 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tremaglio practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Tremaglio's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Tremaglio is licensed in Massachusetts.

CMS data shows 1,485 Medicare services from Dr. Tremaglio across 11 procedure codes in 2024, for 427 Medicare patients. Medicare paid $165,610 for them.

CMS counts 427 Medicare patients who saw Dr. Tremaglio in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 4.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tremaglio's median patient age at 69, with 45% women.

In 2024, Dr. Tremaglio wrote 3,731 Medicare Part D claims for 468 patients. 89% of them were for generic drugs. CMS names the drug for 3,384 of them, across 49 drugs with 11 or more claims each, at $401,276 in total drug cost. In 2023, CMS named 3,302 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Tremaglio for performance year 2024, reported as part of a group. Dr. Tremaglio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tremaglio as offering telehealth.

Dmand AI links 7 papers to Dr. Tremaglio, published from 2015 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Kidney Transplantation and Living Donors. Dr. Tremaglio's most frequent co-authors are Oscar Kenneth Serrano, MD, Caroline Rochon, MD and Joseph Singh, MD.

CMS Open Payments shows 5 general payments to Dr. Tremaglio from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 68% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $23.

Dr. Tremaglio graduated from University of Connecticut School of Medicine in 2010.